GTLB- DVAX
- COLD
- MNST
- https://finance.yahoo.com/quote/GTLB/59.15
- https://finance.yahoo.com/quote/DVAX 14.02
- https://finance.yahoo.com/quote/COLD 31,56
- https://finance.yahoo.com/quote/MNST 96.11
https://www.monsterbevcorp.com
Sector(s): Consumer Defensive
Industry: Beverages—Non-Alcoholic
Full Time Employees: 3,458
Monster Beverage Corporation was founded in 1985 and is headquartered in Corona, California
52 Week Range71.78 - 99.89- Volume
3,506,791 Avg. Volume3,127,206 Market Cap 50.907B Beta (5Y Monthly) 1.01
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
- https://finance.yahoo.com/quote/GTLB/
- 52 Week Range30.74 - 137.00
- Volume
2,367,502 - Avg. Volume1,823,173
Market Cap 8.736B Beta (5Y Monthly) N/A
- xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Sector(s): Real Estate
Industry: REIT—Industrial
Full Time Employees: 16,275
Americold is the world's largest publicly traded REIT focused on the ownership, operation, acquisition and development of temperature-controlled warehouses. Based in Atlanta, Georgia, Americold owns and operates 185 temperature-controlled warehouses, with over 1 billion refrigerated cubic feet of storage, in the United States, Australia, New Zealand, Canada, and Argentina. Americold's facilities are an integral component of the supply chain connecting food producers, processors, distributors and retailers to consumers.
52 Week Range23.96 - 40.85
Volume3,049,636
Avg. Volume2,120,153
Market Cap 8.504B Beta (5Y Monthly) 0.34
- xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
- https://finance.yahoo.com/quote/DVAX/
- 52 Week Range7.26 - 21.39
- Volume
2,322,406 - Avg. Volume2,969,656
Market Cap 1.771B Beta (5Y Monthly) 1.41
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 311
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.
0.2501 -0.0079 -3.06% 33.26 +1.43 +4.49% 12.78 +0.17 +1.35% 3.6000 +1.0300 +40.08% 1.3000 +0.0200 +1.56
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
GTLB
https://www.monsterbevcorp.com
Sector(s): Consumer Defensive
Industry: Beverages—Non-Alcoholic
Full Time Employees: 3,458
Monster Beverage Corporation was founded in 1985 and is headquartered in Corona, California
52 Week Range71.78 - 99.89
| Market Cap | 50.907B |
| Beta (5Y Monthly) | 1.01 |
| Market Cap | 8.736B |
| Beta (5Y Monthly) | N/A |
Sector(s): Real Estate
Industry: REIT—Industrial
Full Time Employees: 16,275
Americold is the world's largest publicly traded REIT focused on the ownership, operation, acquisition and development of temperature-controlled warehouses. Based in Atlanta, Georgia, Americold owns and operates 185 temperature-controlled warehouses, with over 1 billion refrigerated cubic feet of storage, in the United States, Australia, New Zealand, Canada, and Argentina. Americold's facilities are an integral component of the supply chain connecting food producers, processors, distributors and retailers to consumers.
52 Week Range23.96 - 40.85
Volume
Avg. Volume2,120,153
| Market Cap | 8.504B |
| Beta (5Y Monthly) | 0.34 |
| Market Cap | 1.771B |
| Beta (5Y Monthly) | 1.41 |
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 311
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe.
No comments:
Post a Comment